Patents by Inventor Anil Kumar Tripathi

Anil Kumar Tripathi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the Preparation of Abaloparatide
    Publication number: 20220177513
    Abstract: A process for the preparation of Abaloparatide or pharmaceutically acceptable salts. Also described is pure Abaloparatide or pharmaceutically acceptable salts thereof obtained from the process for the preparation of Abaloparatide.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 9, 2022
    Inventors: Ananda Kuppanna, Sureshbabu Jayachandra, Anil Kumar Tripathi, Bulliraju Kamana, Chandrashekhar Shanigaram
  • PROCESS FOR PREPARATION OF PURE PLECANATIDE
    Publication number: 20210363184
    Abstract: The present disclosure provides methods for purified Plecanatide by a two-step purification method, novel intermediates that may be used in the preparation of Plecanatide, and purified Plecanatide compositions.
    Type: Application
    Filed: May 6, 2019
    Publication date: November 25, 2021
    Applicant: Mylan Laboratories Limited
    Inventors: Ananda KUPPANNA, Sureshbabu JAYACHANDRA, Anil Kumar TRIPATHI, Chandrashekhar SHANIGARAM, Bulliraju KAMANA, Sreelatha VANJIVAKA
  • Polymorphic forms of VENCLEXTA
    Patent number: 10800777
    Abstract: The present disclosure relates to crystalline forms of venetoclax and process for their preparation. The present disclosure also relates to process for preparation of amorphous venetoclax.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: October 13, 2020
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murthy Pilli, Rajesh Joshi, Anil Kumar Tripathi, Chandrakant Chaudhri, Kiran Pokharkar, Nagaraju Gottumukkala
  • Combination of clofazimine and imatinib for effective therapy of drug-resistant myeloid leukemia
    Patent number: 10576078
    Abstract: The present invention relates to method of treating chronic myeloid leukemia (CML) or drug resistant CML comprising, administering to human being or any other mammal or animal in need thereof, a therapeutically effective amount of Clofazimine (CFZ) or its pharmaceutically acceptable derivative, analogue, salt or composition; or a combination of a therapeutically effective amount of Clofazimine (CFZ) or its pharmaceutically acceptable derivative, analogue, salt or composition with a tyrosine kinase inhibitor (TKI). The invention also provides the kit for treatment of CML or drug resistant CML.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: March 3, 2020
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Sabyasachi Sanyal, Harish Kumar, Naibedya Chattopadhyay, Ravishankar Ramachandran, Arun Kumarv Trivedi, Sonal Shree, Anagha Ashok Gurjar, Sourav Chattopadhyay, Sapana Kushwaha, Abhishek Kumar Singh, Shikha Dubey, Kiran Lata, Riyazuddin Mohammed, Jiaur Rahaman Gayen, Anil Kumar Tripathi
  • Combination Of Clofazimine And Imatinib For Effective Therapy Of Drug-Resistant Myeloid Leukemia
    Publication number: 20190350928
    Abstract: The present invention relates to method of treating chronic myeloid leukemia (CML) or drug resistant CML comprising, administering to human being or any other mammal or animal in need thereof, a therapeutically effective amount of Clofazimine (CFZ) or its pharmaceutically acceptable derivative, analogue, salt or composition; or a combination of a therapeutically effective amount of Clofazimine (CFZ) or its pharmaceutically acceptable derivative, analogue, salt or composition with a tyrosine kinase inhibitor (TKI). The invention also provides the kit for treatment of CML or drug resistant CML.
    Type: Application
    Filed: August 30, 2018
    Publication date: November 21, 2019
    Inventors: Sabyasachi Sanyal, Harish Kumar, Naibedya Chattopadhyay, Ravishankar Ramachandran, Arun Kumarv Trivedi, Sonal Shree, Anagha Ashok Gurjar, Sourav Chattopadhyay, Sapana Kushwaha, Abhishek Kumar Singh, Shikha Dubey, Kiran Lata, Riyazuddin Mohammed, Jiaur Rahaman Gayen, Anil Kumar Tripathi
  • POLYMORPHIC FORMS OF VENETOCLAX
    Publication number: 20190233416
    Abstract: The present disclosure relates to crystalline forms of venetoclax and process for their preparation. The present disclosure also relates to process for preparation of amorphous venetoclax.
    Type: Application
    Filed: October 13, 2017
    Publication date: August 1, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murthy Pilli, Rajesh Joshi, Anil Kumar Tripathi, Chandrakant Chaudhri, Kiran Pokharkar, Nagaraju Gottumukkala
  • PROCESS FOR THE PREPARATION OF VENETOCLAX
    Publication number: 20190177317
    Abstract: The present disclosure provides novel synthetic process for the preparation of venetoclax. The disclosed processes involve the use of novel intermediates. Processes for the preparation of these intermediates are also disclosed as well as methods for the preparation of particularly useful salts thereof.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 13, 2019
    Applicant: MYLAN LABORATORIES LIMITED
    Inventors: RAJESH JOSHI, ANIL KUMAR TRIPATHI, CHANDRAKANT CHAUDHARI, NAGARAJU GOTTUMUKKALA, KIRAN POKHARKAR, YOGESH SANGVIKAR, LAKSHMANARAO VADALI, SURESH BABU JAYACHANDRA
  • Aryl naphthyl methanone oxime(s) and process for preparation thereof
    Patent number: 9994515
    Abstract: The present invention relates to substituted aryl naphthyl methanone oximes of general formula (I), their process for preparation and their derivatives, salts, pharmaceutical composition thereof and their use in treatment of chronic myelogenous leukemia, acute myelogenous leukemia, lymphoma, multiple myeloma, solid tumor forming cell-lines including such as breast cancer, endometrial cancer colon cancer, prostate cancer and killing of drug resistant cancer stem cells, as subject in need thereof.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: June 12, 2018
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sabyasachi Sanyal, Atul Kumar, Naibedya Chattopadhyay, Jawahar Lal, Arun Kumar Trivedi, Dipak Datta, Srikanta Kumar Rath, Tahseen Akhtar, Shailendra Kumar Dhar Dwivedi, Manisha Yadav, Bandana Chakravarti, Abhishek Kumar Singh, Jay Sharan Mishra, Nidhi Singh, Anil Kumar Tripathi
  • ARYL NAPHTHYL METHANONE OXIME(S) AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20160304442
    Abstract: The present invention relates to substituted aryl naphthyl methanone oximes of general formula (I), their process for preparation and their derivatives, salts, pharmaceutical composition thereof and their use in treatment of chronic myelogenous leukemia, acute myelogenous leukemia, lymphoma, multiple myeloma, solid tumor forming cell- lines including such as breast cancer, endometrial cancer colon cancer, prostate cancer and killing of drug resistant cancer stem cells, as subject in need thereof.
    Type: Application
    Filed: August 29, 2014
    Publication date: October 20, 2016
    Inventors: Sabyasachi Sanyal, Atul Kumar, Naibedya Chattopadhyay, Jawahar Lal, Arun Kumar Trivedi, Dipak Datta, Srikanta Kumar Rath, Tahseen Akhtar, Shailendra Kumar Dhar Dwivedi, Manisha Yadav, Bandana Chakravarti, Abhishek Kumar Singh, Jay Sharan Mishra, Nidhi Singh, Anil Kumar Tripathi
  • Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
    Patent number: 7868029
    Abstract: The present invention relates to processes for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles (5a) from cyclohexanes (2a) and cyclohexanones (3a) as intermediate.
    Type: Grant
    Filed: September 17, 2003
    Date of Patent: January 11, 2011
    Assignee: Generics [UK] Limited
    Inventors: Ashwini Kumar Gupta, Balu Aghav, Anil Kumar Tripathi, Abhay Gaitonde